There was much activity in the human epidermal growth factor receptor 2 (HER2) space at the recent 45th Annual San Antonio Breast Cancer Symposium ......READ MORE
Treatment burden is an important dimension of the overall experience of patients with breast cancer. Increasingly, the oncology community is recogn......READ MORE
Efforts are underway to integrate genetic and molecular data with the standard prognostic factors in human epidermal growth factor receptor 2–posit......READ MORE
Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic......READ MORE
